Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Japanese Journal of Clinical Oncology|January 14, 2009
Evaluation of the safety and compliance of 3-week cycles of vinorelbine on days 1 and 8 and cisplatin on day 1 as adjuvant chemotherapy in Japanese patients with completely resected pathological stage IB to IIIA non-small cell lung cancer: a retrospective studyTakehito Shukuya, Toshiaki Takahashi, Akihiro Tamiya, et al.
Lung Cancer (Amsterdam, Netherlands)|August 25, 2009
Comparison of chemotherapy for unresectable pulmonary high-grade non-small cell neuroendocrine carcinoma and small-cell lung cancerSatoshi Igawa, Reiko Watanabe, Ichiro Ito, et al.
Anticancer Research|July 15, 2009
Gefitinib plus paclitaxel after failure of gefitinib in non-small cell lung cancer initially responding to gefitinibTakehito Shukuya, Toshiaki Takahashi, Akihiro Tamiya, et al.
Anticancer Research|January 31, 2012
Impacts of treatment lines and initiation timing of erlotinib for advanced non-small cell lung cancerTakuya Aoki, Satoshi Igawa, Naoki Furuya, et al.
Thoracic Cancer|April 1, 2021
Prognostic significance of galectin-3 expression in patients with resected NSCLC treated with platinum-based adjuvant chemotherapySeiichiro Kusuhara, Satoshi Igawa, Masaaki Ichinoe, et al.
Biochimica Et Biophysica Acta. Proteins and Proteomics|May 13, 2018
Prognostic significance of G6PD expression and localization in lung adenocarcinomaRyo Nagashio, Shota Oikawa, Kengo Yanagita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 14, 2012
[Efficacy of chemotherapy with carboplatin-paclitaxel plus bevacizumab for previously treated patients with advanced non-small cell carcinoma]Sachiyo Maki, Satoshi Igawa, Sakiko Otani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 19, 2010
[A case of recurrent invasive thymic cancer showing a stable disease to carboplatin plus paclitaxel]Satoshi Igawa, Nobuyuki Yanagisawa, Shinichi Makita, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2014
Evaluation of gefitinib efficacy according to body surface area in patients with non-small cell lung cancer harboring an EGFR mutationSatoshi Igawa, Masashi Kasajima, Mikiko Ishihara, et al.
Investigational New Drugs|June 21, 2017
Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancerSatoshi Igawa, Sakiko Otani, Shinichiro Ryuge, et al.
Pageof 11